Skip to main content
. 2017 Dec 15;12(12):e0189354. doi: 10.1371/journal.pone.0189354

Table 2. Residual tumor cases in re-TURBT according to initial pathology.

Parameter  No residual tumor (n = 91) Residual tumor (n = 107) P
Gender (Female) 13 (14.3%) 21 (19.6%) 0.211
Age 0.052
<60 34 (37.4%) 42 (39.3%)
61–70 37 (40.7%) 28 (26.2%)
70< 20 (22.0%) 37 (34.6%)
Previous UUTa History 7 (7.7%) 6 (5.6%) 0.379
Prev. Recur History 4 (4.4%) 10 (9.3%) 0.394
T stage     0.841
Ta 13 (14.3%) 17 (15.9%)  
T1 76 (83.5%) 85 (79.4%)  
CIS 2 (2.2%) 5 (4.7%)
Grade     0.017
Unknown 0(0%) 0 (0%)  
Low grade 18 (19.8%) 9 (8.4%)  
High grade 73 (80.2%) 98 (91.6%)  
Concomitant CIS 5 (5.5%) 19 (17.8%) 0.007
Size     0.089
≥3Cm 21 (23.1%) 35 (32.7%)  
Tumor Number     0.007
1 53 (58.2%) 39 (31.2%)  
2–7 31 (34.1%) 51 (47.7%)  
7< 7 (7.7%) 17 (15.9%)  
CRPb 76.78±18.91 69.37±16.30 0.601

aUUT = Upper urinary tract tumor

bCRP = C-reactive protein